Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?

Psychiatric Centre Rigshospitalet · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
alcoholusedisorderfmriglpglucagonsemaglutide
alcohol abuse, alcohol addiction, alcohol dependence, alcohol use disorder, glp-1, glucagon-like peptide 1, semaglutide, fmri, mrs, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 899455
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.